Novartis | NVS - Interest Income


Novartis reported $6M in Interest Income for its fiscal quarter ending in March of 2024.





Interest Income Change Date
AbbVie USD 59M 13M Dec/2025
AstraZeneca USD 73M 62M Mar/2026
Bausch Health Companies USD 9M 6M Dec/2025
Biogen USD 37.9M 700K Mar/2026
Corcept Therapeutics USD 5.42M 399K Dec/2025
Drreddys Laboratories INR 796M 332M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
Glaxosmithkline GBP 26M 24M Sep/2025
J&J USD 2.14 237M Mar/2026
Merck USD 69M 27M Dec/2025
Pacira USD 2.3M 6.24M Dec/2025
Pfizer USD 115M 51M Mar/2026
Phibro Animal Health USD 0.08 0.09 Dec/2024
Sanofi EUR 33M 81M Dec/2025
Sanofi EUR 114M 38M Sep/2025
Supernus Pharmaceuticals USD 2.02M 254K Dec/2025
Zoetis USD 25M 1000K Dec/2025